BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 38589405)

  • 1. Unveiling G-protein coupled receptor kinase-5 inhibitors for chronic degenerative diseases: Multilayered prioritization employing explainable machine learning-driven multi-class QSAR, ligand-based pharmacophore and free energy-inspired molecular simulation.
    Bhattacharjee A; Kar S; Ojha PK
    Int J Biol Macromol; 2024 Jun; 269(Pt 1):131784. PubMed ID: 38697440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Generation, QSAR, and Molecular Dynamic Simulation Studies for Virtual Screening of DNA Polymerase Theta Inhibitors.
    Qin Z; Liu L; Gao M; Feng W; Huang C; Liu W
    Curr Comput Aided Drug Des; 2024 May; ():. PubMed ID: 38779737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus holistic virtual screening for drug discovery: a novel machine learning model approach.
    Moshawih S; Bu ZH; Goh HP; Kifli N; Lee LH; Goh KW; Ming LC
    J Cheminform; 2024 May; 16(1):62. PubMed ID: 38807196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerating Molecular Docking using Machine Learning Methods.
    Bande AY; Baday S
    Mol Inform; 2024 Jun; 43(6):e202300167. PubMed ID: 38850231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docking Score ML: Target-Specific Machine Learning Models Improving Docking-Based Virtual Screening in 155 Targets.
    Liu H; Hu B; Chen P; Wang X; Wang H; Wang S; Wang J; Lin B; Cheng M
    J Chem Inf Model; 2024 Jul; ():. PubMed ID: 38958413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inferring molecular inhibition potency with AlphaFold predicted structures.
    Oliveira PF; Guedes RC; Falcao AO
    Sci Rep; 2024 Apr; 14(1):8252. PubMed ID: 38589418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Materials discovery with extreme properties
    Kim H; Choi H; Kang D; Lee WB; Na J
    Chem Sci; 2024 May; 15(21):7908-7925. PubMed ID: 38817562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Potent Small-Molecule PCSK9 Inhibitors Based on Quantitative Structure-Activity Relationship, Pharmacophore Modeling, and Molecular Docking Procedure.
    Mahmoudi A; Butler AE; Banach M; Jamialahmadi T; Sahebkar A
    Curr Probl Cardiol; 2023 Jun; 48(6):101660. PubMed ID: 36841313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Based Design of Novel MAO-B Inhibitors: A Review.
    Mateev E; Georgieva M; Mateeva A; Zlatkov A; Ahmad S; Raza K; Azevedo V; Barh D
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning accelerates pharmacophore-based virtual screening of MAO inhibitors.
    Cieślak M; Danel T; Krzysztyńska-Kuleta O; Kalinowska-Tłuścik J
    Sci Rep; 2024 Apr; 14(1):8228. PubMed ID: 38589405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Field and atom-based 3D-QSAR models of chromone (1-benzopyran-4-one) derivatives as MAO inhibitors.
    Saha M; Gupta S; Dhiman S; Asati V; Ali A; Ali A
    J Biomol Struct Dyn; 2023; 41(21):12171-12185. PubMed ID: 36650997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
    Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge based identification of MAO-B selective inhibitors using pharmacophore and structure based virtual screening models.
    Boppana K; Dubey PK; Jagarlapudi SA; Vadivelan S; Rambabu G
    Eur J Med Chem; 2009 Sep; 44(9):3584-90. PubMed ID: 19321235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machine learning driven web-based app platform for the discovery of monoamine oxidase B inhibitors.
    Kumar S; Bhowmik R; Oh JM; Abdelgawad MA; Ghoneim MM; Al-Serwi RH; Kim H; Mathew B
    Sci Rep; 2024 Feb; 14(1):4868. PubMed ID: 38418571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the Molecular Determinant of Reversible Human Monoamine Oxidase B Inhibitors Containing 2H-Chromen-2-One Core: Structure-Based and Ligand-Based Derived Three-Dimensional Quantitative Structure-Activity Relationships Predictive Models.
    Mladenović M; Patsilinakos A; Pirolli A; Sabatino M; Ragno R
    J Chem Inf Model; 2017 Apr; 57(4):787-814. PubMed ID: 28291352
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.